Real-time enrollment status for this lung cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 7:18 AM UTC
| NCT Number | NCT06119581 |
| Recruiting Status | Recruiting |
| Condition | Lung Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 1,016 participants |
| Active Locations | 91 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | January 21, 2026 (Jan 21, 2026) |
As of March 2, 2026: Clinical trial NCT06119581 is currently recruiting participants. This clinical trial study for lung cancer is actively seeking new participants at 91 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06119581 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 91 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06119581 was last updated Jan 21, 2026 (January 21, 2026). HelloStudys verifies this status automatically.